January 16, 2020
Paul Holtzheimer, MD - ADAA Board Member
and
Deep brain stimulation (DBS) is emerging as a potential intervention for patients with highly treatment-resistant depression (TRD). Early, open-label studies supported the safety and potential efficacy of DBS for TRD but later randomized, controlled trials have yielded mixed results.
October 30, 2019
Joy Burkhard, MBA
and
Catherine Monk, PhD
and
Margaret Altemus, MD
and
Rahil Briggs, PsyD
and
May 23, 2019
June 13, 2019
David H. Rosmarin, PhD, ABPP
and
December 19, 2018
Amanda Baker, PhD
and
Rachel Freed, PhD
and
Sarah Kleiman, PhD
and
December 13, 2018
Dan Capron, PhD
and
Elizabeth Dalton, PhD
and
November 27, 2018
Hannah Bergman, PhD
and
Vasiliki Michopoulos, PhD - ADAA Board
and
August 23, 2018
Ali B. Klein, BA
and
Michelle Bovin, PhD
and
April 26, 2018
Andrea G. Batton, LCPC
and
Denise Egan Stack, LMHC
and
Jon Hershfield, LCMFT
and
May 24, 2018
